DrugPatentWatch Database Preview

Details for Patent: 6,004,297

« Back to Dashboard

Which drugs does patent 6,004,297 protect, and when does it expire?

Patent 6,004,297 protects NORDITROPIN NORDIFLEX, LEVEMIR FLEXPEN, NOVOLOG FLEXPEN, NOVOLOG MIX 70/30 FLEXPEN, and VICTOZA, and is included in five NDAs.

This patent has thirty patent family members in twenty-two countries.

Summary for Patent: 6,004,297

Title:	Injection syringe
Abstract:	An injection syringe comprises a housing (1), a piston rod (6) with a non-circular cross-section and an outer thread (7), a piston rod drive which includes a piston rod guide (85) mating with the cross-section of the piston rod (6), and a nut (4) which is not axially displaceable and which mates with the thread (7) of the piston rod (6) to form a self-locking thread connection. Rotation of a dose setting element (81) causes an injection button to be screwed out to project from the housing (1). When the injection button (88) is pushed axially, such axial movement is transformed, by way of the threaded coupling, into a rotation of one of the piston drive elements (85) relative to the other one (4). A unidirectional coupling between the nut member (4) and the piston rod guide (85) allows rotation in one direction by which the piston rod (6) is transported in a distal direction. The coupling has an initial reluctance to be overcome before rotation takes place, said reluctance being large enough to resist torques exerted during the dose setting.
Inventor(s):	Steenfeldt-Jensen; S.o slashed.ren (Hornb.ae butted.k, DK), Hansen; Steffen (Hiller.o slashed.d, DK)
Assignee:	Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:	09/238,849
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,004,297
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 6,004,297
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 6,004,297

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Novo Nordisk Inc	NORDITROPIN NORDIFLEX	somatropin recombinant	INJECTABLE;INJECTION	021148-004	Oct 1, 2004		DISCN	No	No			Y
Novo Nordisk Inc	NORDITROPIN NORDIFLEX	somatropin recombinant	INJECTABLE;INJECTION	021148-005	Oct 1, 2004		DISCN	No	No			Y
Novo Nordisk Inc	NORDITROPIN NORDIFLEX	somatropin recombinant	INJECTABLE;INJECTION	021148-006	Oct 1, 2004		DISCN	No	No			Y
Novo Nordisk Inc	NORDITROPIN NORDIFLEX	somatropin recombinant	INJECTABLE;INJECTION	021148-007	Mar 10, 2009		DISCN	No	No			Y
Novo Nordisk Inc	LEVEMIR FLEXPEN	insulin detemir recombinant	INJECTABLE;SUBCUTANEOUS	021536-002	Jun 16, 2005		DISCN	No	No			Y

Foreign Priority and PCT Information for Patent: 6,004,297

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Denmark	00130/98	Jan 30, 1998

International Family Members for US Patent 6,004,297

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	197408
Australia	2265099
Australia	748277
Brazil	9906857
Canada	2305634